ABSTRACT OBJECTIVE: To develop and optimize a rapid molecular method for diagnosing campylobacteriosis directly from a clinical fecal sample and at the same time for determining the most common causing agents -C. jejuni/coli. MATERIALS AND METHODS: 38 clinical fecal samples from hospitalized patients with diarrheal syndrome were tested using a rapid immunochromatographic test. All positive samples were tested for confi rmation by culturing in a microaerophilic atmosphere. The Eva Green real-time mPCR reaction of a direct fecal sample was conducted using the "IQ5TM Real-Time PCR System" apparatus. RESULTS: Out of 38 clinical fecal samples which were ICT positive, 18 strains were isolated by culture, namely, 17 of C. jejuni and 1 of C. coli. The Eva Green real-time mPCR reaction also reported 18 positive samples for Campylobacter, out of which 17 were of C. jejuni and only one of C.coli. CONCLUSION: We developed and optimized the Eva Green real-time mPCR for the detection and species differentiation of C. jejuni/coli directly from a clinical fecal sample. The molecular analysis we described has a 100% sensitivity and specifi city when comparing the results obtained by it to those of the culture method, which is currently the "gold standard" in the diagnosis of campylobacteriosis (Tab. 2, Fig. 1, Ref. 6 ). Text in PDF www.elis.sk.
Introduction
Enteropathogenic bacteria are the cause of acute infectious diarrhea, which is a global health problem (3) (4) (5) (6) . In our country, routine tests for Campylobacter spp.
are not yet performed on diarrheal patients, and if done, it is by using traditional culture methods, which are slow, laborious and capricious. Very rarely the microbiological laboratories in Bulgaria perform species characteristics of the most common strains of C. jejuni and C. coli, thus making epidemiological studies on campylobacteriosis diffi cult (1, 4) .
Materials and methods
For the period of August 2016 -October 2016, 38 clinical fecal samples of hospitalized patients aged between 0 and 7 years and suffering from diarrheal syndrome at the Hospital for Infectious Diseases, Sofi a were tested. The clinical samples were tested using a rapid immunochromatographic test (ICT) (CerTest Biotec) for the Campylobacter antigen. All positive samples were tested for confi rmation using culturing. The cultures were grown in a microaerophilic atmosphere generated by a gas pack in an anaerobic jar (Oxoid USA) at 42-43 °С for 24-72 hours. The isolates were biochemically differentiated by a positive reaction of sodium hippurate hydrolysis and/or positive reaction of indoxyl acetate hydrolysis for C. jejuni and positive reaction of indoxyl acetate hydrolysis, and negative reaction of sodium hippurate hydrolysis for C. coli. DNA extraction. Bacterial DNA from the clinical fecal samples was extracted using a ready-for-use kit QUIampDNABloodMiniKit (QUIAGEN, Germany) in accordance with the manufacturer's instructions (Eva Green real-time multiplex PCR). The approved PCR method for simultaneous detection and differentiation of C. jejuni/coli directly from a fecal sample is based on three pairs of primers, which until now were not included together in a common PCR reaction: primers -AB F2/R2, amplifying a specifi c region of the cj041 gene for C. jejuni, ceuE F/R, amplifying a specifi c region of the ceuE gene for C. Coli, and primers pair camp F2/R2, amplifying a specifi c region of the genus gene for Campylobacter spp. The primers used and their sequences are provided in Table 1 . Two reference strains are also included, namely 33559ATCC for C. coli and 335560 of C. jejuni, used as positive controls and ddH 2 0 used as a negative control (Tab. 1).
The Eva Green real-time mPCR analysis is optimized to be conducted in a fi nal reaction volume of 25 μl at the specifi ed primers and conditions 1 х Taq DNA Polymerase buffer; 2. The Eva Green real-time mPCR reaction takes place in an "IQ5TM Real-Time PCR System" under the following conditions: the fi rst step is denaturation for 10 min. at 95 °C, followed by 29 cycles, each consisting of 15 sec. of denaturation at 90 °C, 20 sec. of 58 °C hybridization and 25 sec. of 60 °C elongation; while the latter fi nal step of elongation lasted 5 min. at 72 °C. The resulting amplicons measure 108 bp, 72 bp and 74 bp in size, while these DNA fragments correspond to the camp genes for Campylobacter spp., CeuE for C. coli and cj0414 for C. jejuni.
Determining the analytical sensitivity and specifi city of the Eva Green real-time mPCR method
For determining the analytical specifi city, a group of commonly isolated gastroenteritis-causing bacteria was selected, particularly Y.enterocolitica, E.coli stx1d, E. coli O104, Sh. fl exneri, S. Typhi, Cl. diffi cile and S. aureus toxC. The strains АТСС 33560 and C-14.2 were used as a positive control for C. jejuni and C. coli, respectively. А 10х DNA of the cultures of the respective strains was used.
For determining the analytical sensitivity, a series of dilutions of a tenfold bacterial suspension of C. jejuni and C. coli in saline was used. Volumes of 10 μl of each dilution were used to artifi cially inoculate feces which were negative for campylobacter. The QUIampDNABloodMiniKit was used for DNA extraction.
Results and discussion
All fecal samples were tested for C. jejuni/coli using three separate methods: ICT, culture method and using the Eva Green real-time mPCR. The results obtained are provided in Table 2 .
А rapid immunochromatographic test (ICT) for the Campylobacter antigen has been performed on clinical samples of patients with diarrheal syndrome aged between 0 and 7 years and hospitalized at the Hospital for Infectious Diseases, Sofi a, and all positive samples have been verifi ed with a culture and molecular test at the Centre for Infectious and Parasitic Diseases, Sofi a.
Out of 38 fecal samples which were ICT positive, 18 strains were isolated in a culture; 17 of C. jejuni and 1 of C. coli. This analysis provides a rapid and more reliable detection of bacterial cells compared to the conventional culture methods using biochemical differentiation. The amplifi cation curves of the products can be monitored in real time, and the melting temperatures typical of the target genes are respectively: 78.80 °C for C. jejuni, 76.80 °C for C. coli and 82.80 °C for Campylobacter spp. at the optimal melting temperature of the primers (Т а ) of 58 °C, based on which we optimized the protocol (Fig. 1) .
Out of 38 clinical samples tested for C. jejuni/coli, the PCR analysis reported 18 positive samples for Campylobacter while in 17 of them the PCR products had the typical melting temperatures for C. jejuni and only one for C. coli. All other samples were negative for Campylobacter spp.
Determining the analytical sensitivity of the Eva Green real-time mPCR method.
In each PCR reaction for analytical sensitivity we used 7.5 μl of concentrated DNA extracted from artifi cially inoculated feces with serial dilutions of 10 μl of a tenfold bacterial suspension. The analytical sensitivity of the test is approximately 103 CFU per 150 μl of liquid stool. This analytical sensitivity is signifi cantly higher than any published to date (2). The molecular analysis we described has a 100% sensitivity and specifi city when comparing the results obtained by it to those of the culture method, which is currently the "gold standard" in the diagnosis of campylobacteriosis. In this study, the PCR method is inferior to ICT only in terms of speed.
Conclusion
The fecal samples of patients with acute enterocolitis may contain a variety of pathogenic bacteria. For the purposes of early initiation of etiological treatment, the rapid detection of the bacterial agent causing the particular disease and providing a timely diagnosis are important. We developed the Eva Green real-time mPCR analysis as a rapid, sensitive and specifi c method for the diagnosis of campylobacteriosis directly from a clinical fecal sample and at the same time determined the two most frequently isolated species -C. jejuni and C. coli for the needs of molecular epidemiology. This method will be very useful in emergency situations such as in controlling epidemic situations, pediatric infectology, as well as in immunosuppressed patients.
